Literature DB >> 32281731

Different eplet software programs give discordant and incorrect results: An analysis of HLAMatchmaker vs Fusion Matchmaker Eplet calling software.

Gabriella Tassone1, Dianne De Santis1,2, Irena Vukovic1, Jonathan Downing1, Olga Patricia Martinez1,2, Lloyd J D'Orsogna1,2.   

Abstract

HLA eplet matching is a novel approach to define acceptable HLA mismatches for transplant recipients. We performed an eplet analysis of three different transplant case-series to determine if the available software programs gave accurate results. Eplet analysis was performed for three different transplant case-series typed by NGS for all HLA class I and II loci. The three different HLA datasets were entered into both the HLAMatchmaker program (v2.1) and OLI Fusion MatchMaker (v4.2) software tools. Eplet results which were discordant were cross referenced against eplet registry and published HLA allele sequence data to determine the correct assignments. The comparison reveals that there was poor concordance between the two eplet programs. Analysis of the same donor/recipient pair often gave rise to different total eplet scores, incorrect eplet mismatches and antibody verification status, and both programs have eplets assigned to incorrect HLA alleles. Overall, the OLI Fusion MatchMaker eplet tool gave more accurate and useful eplet results. Eplet matching is still primarily a research tool. Before eplet matching can enter routine clinical practice further work is required to validate the accuracy of available eplet software programs. Incorrect eplet assignment could have serious adverse consequences in the clinical transplant setting.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  HLA; acceptable mismatch; eplets; kidney transplantation; software

Mesh:

Year:  2020        PMID: 32281731     DOI: 10.1111/tan.13897

Source DB:  PubMed          Journal:  HLA        ISSN: 2059-2302            Impact factor:   4.513


  5 in total

Review 1.  Emerging monitoring technologies in kidney transplantation.

Authors:  Abdulla Ehlayel; K'joy J A Simms; Isa F Ashoor
Journal:  Pediatr Nephrol       Date:  2021-02-01       Impact factor: 3.714

2.  Development of an immunogenicity score for HLA-DQ eplets: A conceptual study.

Authors:  Lara Schawalder; Gideon Hönger; Marc Kleiser; Michelle R van Heck; Loes A L van de Pasch; Sanne Vendelbosch; Erik H Rozemuller; Stefan Schaub
Journal:  HLA       Date:  2020-10-28       Impact factor: 4.513

3.  A Comprehensive Evaluation of the Antibody-Verified Status of Eplets Listed in the HLA Epitope Registry.

Authors:  Suzanne Bezstarosti; Kim H Bakker; Cynthia S M Kramer; Johan W de Fijter; Marlies E J Reinders; Arend Mulder; Frans H J Claas; Sebastiaan Heidt
Journal:  Front Immunol       Date:  2022-01-28       Impact factor: 7.561

4.  HLA-EPI: A new EPIsode in exploring donor/recipient epitopic compatibilities.

Authors:  Estelle Geffard; Léo Boussamet; Alexandre Walencik; Florent Delbos; Sophie Limou; Pierre-Antoine Gourraud; Nicolas Vince
Journal:  HLA       Date:  2021-12-16       Impact factor: 8.762

5.  HLA-DQ-Specific Recombinant Human Monoclonal Antibodies Allow for In-Depth Analysis of HLA-DQ Epitopes.

Authors:  Suzanne Bezstarosti; Cynthia S M Kramer; Marry E I Franke-van Dijk; Manon Vergunst; Kim H Bakker; Merve Uyar-Mercankaya; Rico Buchli; Dave L Roelen; Johan W de Fijter; Frans H J Claas; Sebastiaan Heidt
Journal:  Front Immunol       Date:  2022-01-07       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.